secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001104659-23-104769
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics receives Nasdaq delisting notice for bid price below $1.00 for 30 consecutive days
--------------------------------------------------------------------------------

- Received Nasdaq notice on Sept 27, 2023 for non-compliance with minimum bid price requirement (Rule 5550(a)(2)).
- Common stock closed below $1.00 per share for 30 consecutive business days.
- Company has 180-day grace period through March 25, 2024 to regain compliance by closing at $1.00+ for 10+ consecutive days.
- If not compliant by March 25, 2024, may seek second 180-day period if it meets initial listing criteria and intends to reverse split.
- Company will monitor bid price and consider options; no assurance of maintaining listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923104769/0001104659-23-104769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923104769/tm2327174d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-104769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer